The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes

Marwa Ali Almadhi, Abdulkarim Abdulrahman, Abdulla Alawadhi, Ali A.Rabaan, Manaf AlQahtani
doi: https://doi.org/10.1101/2020.09.22.20199422

Article Information

doi 
https://doi.org/10.1101/2020.09.22.20199422
History 
  • September 22, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Marwa Ali Almadhi1,
  2. Abdulkarim Abdulrahman1,2,
  3. Abdulla Alawadhi1,3,
  4. Ali A.Rabaan4 and
  5. Manaf AlQahtani1,5,6,*
  1. 1Medical and Research team, National Taskforce for Combating the Coronavirus (COVID-19), Bahrain
  2. 2Medical Resident, Mohammed Bin Khalifa Cardiac Centre, Bahrain
  3. 3Clinical Psychologist, Bahrain Defence Force hospital, Bahrain
  4. 4Molecular diagnostic Laboratory, John Hopkins Aramco Healthcare, Dhahran, Saudi Arabia
  5. 5Associate Professor in Microbiology at Royal College of Surgeons in Ireland, Bahrain
  6. 6Consultant Infectious disease and clinical microbiologist, Bahrain Defence Force hospital, Bahrain
  1. ↵* Corresponding author; email: drmanaf{at}gmail.com
Back to top
Posted September 22, 2020.
Download PDF
Data/Code
Email
The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes
Marwa Ali Almadhi, Abdulkarim Abdulrahman, Abdulla Alawadhi, Ali A.Rabaan, Manaf AlQahtani
medRxiv 2020.09.22.20199422; doi: https://doi.org/10.1101/2020.09.22.20199422
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area